Abstract

The peritoneum is one of the most common sites of gastric cancer recurrence or metastasis.Peritoneal metastasis seriously affects the patients life quality and shortens patients survival time,so early diagnosis and active treatment have a major impact on the prognosis. Continuous studies of some biomarkers and extensive using of ncw imaging technology make the early diagnosis of peritoneal metastasis more promising.Simultaneously,with the rapid development of intraperitoneal chemotherapy and molecular targeted therapy,there are more options in the treatment. Key words: Stomach neoplasms; Neoplasm seeding; Diagnosis; Therapeutic uses

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.